Cancer patients are at a heightened risk of developing venous thromboembolism (VTE), which includes conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). LMWH is frequently utilized in cancer patients to manage and prevent these complications. It is preferred in this population due to its efficacy, safety profile, and convenience.
